H19 and gastric cancer: Despite the remarkable discoveries regarding the utilization of tissue/serum H19 levels in assessing the clinical characteristics of GC patients, there remains a need for further investigation to establish the expression level or specific single nucleotide polymorphisms (SNPs) of H19 as a suitable biomarker.